Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Aust N Z J Obstet Gynaecol ; 63(6): 821-824, 2023 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-37317572

RESUMO

Perinatal mental health (PMH) disorders affect about one in seven women in the peripartum period with significant maternal and neonatal effects. It is important to understand trends in PMH to plan for necessary resource allocation. This study reviews the PMH trends in a major tertiary obstetric centre over 10 years from 2013 to 2022. Over this period there was a significant increase in the rates of anxiety from 7.4 to 18.4% (P < 0.001), depression from 13.6 to 16.3% (P < 0.001) and anxiety and/or depression from 16.5 to 22.6% (P < 0.001). These findings provide further information for resource allocation to improve long-term outcomes.


Assuntos
Transtornos Mentais , Saúde Mental , Gravidez , Recém-Nascido , Feminino , Humanos , Transtornos Mentais/epidemiologia , Ansiedade/epidemiologia , Ansiedade/psicologia , Depressão/epidemiologia , Depressão/psicologia
2.
Australas Psychiatry ; 29(3): 278-281, 2021 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-33070625

RESUMO

OBJECTIVE: To discuss challenges with the diagnosis of autoimmune psychosis (AP) in people with chronic psychotic disorders. METHOD: We present a case of a 23-year-old man with an exacerbation of treatment-refractory psychosis after receiving intravenous immunoglobulin (IVIG) for suspected AP, diagnosed 4 years after the onset of psychosis. We highlight the diagnostic and management challenges in such cases. RESULTS: The diagnosis of AP in people with long-standing illness relies on the interpretation of non-specific clinical and laboratory findings in individuals with psychosocial problems and challenges of acceptance and adherence to complex medical investigations and treatments. Equivocal results from investigations undertaken without logical clinical reasoning can lead to inappropriate interventions that are costly and can cause iatrogenic harm. CONCLUSION: Psychiatrists should restrict screening for antineuronal antibodies in people with chronic psychosis to those with higher risk features such as persistent treatment refractory symptoms with concurrent neurological signs and symptoms. Further research informing the clinical circumstances for antineuronal antibody testing is needed.


Assuntos
Autoanticorpos/sangue , Imunoglobulinas Intravenosas/efeitos adversos , Psicoses Induzidas por Substâncias/tratamento farmacológico , Transtornos Psicóticos/tratamento farmacológico , Transtornos Psicóticos/terapia , Autoanticorpos/líquido cefalorraquidiano , Encefalite , Humanos , Imunoglobulinas Intravenosas/administração & dosagem , Masculino , Transtornos Psicóticos/diagnóstico , Receptores de N-Metil-D-Aspartato , Adulto Jovem
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...